Vernus AI CEO Jimmy Lin to Deliver Keynote at the SBIC 2026 Opening Ceremony
On Thursday, October 29, 2026, Jimmy Yen-Chu Lin, Founder & CEO of Vernus AI, will deliver a keynote speech at the opening ceremony of the 2026 Seongnam Bio-Healthcare International Convention (SBIC) in Korea.
The ceremony is expected to bring together approximately 1,000 biohealth professionals from Korea and around the world. Jimmy’s talk, “AI Found the Molecule. Now What? From AI Drug Discovery to Global Biohealth Business,” will look at how advances in AI-driven drug discovery and manufacturing are reshaping the biohealth industry and its business models. He will also discuss the strategies and ecosystem needed to turn technological innovation into commercialization and global business opportunities.
Meet us at SBIC
If you are attending SBIC, we would love to meet you there. For more information about the convention, please visit the official SBIC website.
About Vernus AI
Vernus AI (睿泉生技) builds ReAIX, a family of platforms that combine AI, physics-based simulation and annealing-based optimization to help pharmaceutical teams find better process conditions with fewer experiments.